North America blood purification equipment market is projected to grow by 5.6% annually in the forecast period and reach $5,100.8 million by 2031, driven by the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
Highlighted with 22 tables and 40 figures, this 92-page report “North America Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hemodialysis Device
• Blood Filtration Device
• CRRT Device
• Hemoperfusion Device
• Plasma Exchange Device
• Other Products
Based on Portability, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Portable Equipment
• Stationary Equipment
Based on Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Renal Diseases
• Sepsis
• Other Indications
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Dialysis Centers
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aethlon Medical, Inc.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cerus Corporation
CytoSorbents Corporation
Fresenius SE and Co. KGaA
Healthwell Medical Tech. Co., Ltd.
Infomed SA
Jafron Biomedical Co., Ltd.
Kaneka Corporation
Nikkiso Co., Ltd.
Spectral Medical Inc.
SWS Medical Group
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
